By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cyclacel Pharmaceuticals, Inc. 

200 Connell Drive
Suite 1500
Berkeley Heights  New Jersey  07922  U.S.A.
Phone: 908-517-7330 Fax: 866-271-3466


SEARCH JOBS








Company News
Cyclacel Pharmaceuticals, Inc. (CYCC)'s Seliciclib-Sapacitabine Abstract Selected For Oral Presentation At The 2016 ASCO Annual Meeting 5/19/2016 10:19:08 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports First Quarter 2016 Financial Results 5/12/2016 8:40:59 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Release First Quarter 2016 Financial Results 5/4/2016 7:53:29 AM
Cyclacel Pharmaceuticals, Inc. (CYCC)’s Second-Generation CDK2/9 Inhibitor, CYC065, Is An Effective Inducer Of Cell Death In B-Cell Lymphoma And Synergizes With Bcl-2 Or BET Inhibitors 4/18/2016 10:30:30 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Fourth Quarter And Full Year 2015 Financial Results 3/25/2016 8:00:46 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Release Fourth Quarter And Full Year 2015 Financial Results 3/17/2016 8:10:43 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Receipt Of Nasdaq Staff Determination; Company To Request Hearing 2/8/2016 7:34:20 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) To Present At The 18th Annual BIO CEO & Investor Conference 2/2/2016 8:05:51 AM
Cyclacel Pharmaceuticals, Inc. (CYCC) Reviews 2015 Achievements And Announces Key Business Objectives For 2016 1/11/2016 8:24:26 AM
Molecular Basis For Development Of Cyclacel Pharmaceuticals, Inc. (CYCC)’s CYC065 CDK2/9 Inhibitor In Triple-Negative Breast Cancer Presented At San Antonio Breast Cancer Symposium 12/14/2015 7:41:02 AM
12345678910...
//-->